1.Surgical Outcomes of Arthroscopic Modified Brostrom Procedure in Chronic Lateral Ankle Instability.
Min Seok CHA ; Seung Do CHA ; Eung Soo KIM
Journal of Korean Foot and Ankle Society 2013;17(4):283-287
PURPOSE: To evaluate the result of arthroscopic modified Brostrom procedure with suture anchor for chronic lateral ankle instability. MATERIALS AND METHODS: Fifty-two patients with chronic lateral ankle instability were analyzed, who underwent arthroscopic modified Brostrom procedure between December 2010 and May 2012. Clinical evaluation was performed using AOFAS scroring and Sefton grading system. RESULTS: The average AOFAS hind foot score increased from preoperative 61.9 to 88.8 at the last follow up. There were 35 excellent, 9 good, 4 fair, 4 poor results according to Sefton grading system. For one patient, lateral ankle instability recurred. CONCLUSION: Arthroscopic modified Brostrom procedure is considered to be an effective and satisfactory technique.
Ankle*
;
Arthroscopy
;
Follow-Up Studies
;
Foot
;
Humans
;
Suture Anchors
2.A Case of Transient Radiographic Progression during Treatment of Pulmonary Tuberculosis: Early CT Findings.
Tuberculosis and Respiratory Diseases 2008;65(4):339-342
Early CT findings of transient radiographic progression (TRP) during treatment of active pulmonary tuberculosis including subpleural, interlobular or intralobular septal thickening and micronodules are shown in the present case. Late CT findings of TRP are subpleural, enhancing nodular infiltration with internal low attenuation. These CT features accompanied by a lack of clinical worsening in young patients taking antituberculous medication due to pulmonary tuberculosis can help to differentiate TRP from other disease entities.
Humans
;
Lung
;
Tuberculosis
;
Tuberculosis, Pulmonary
3.Clinical study of color doppler ultrasonography in IVF-ET.
Young Beom CHA ; Hong Ki KIM ; Seung Jae LEE ; Jong Min PARK ; Young Ho LEE
Korean Journal of Obstetrics and Gynecology 1991;34(5):697-704
No abstract available.
Ultrasonography, Doppler, Color*
4.Clinical Study of the Risk Factors of Recurrence after the Antiepileptic Drug Discontinuation in Childhood Epilepsy.
Young Eun LEE ; Byung Ho CHA ; Whang Min KIM ; Jae Seung YANG ; Jong Soo KIM
Journal of the Korean Child Neurology Society 1997;5(1):31-37
59 children seen from Jan. 1990 to Jun. 1994 with epilepsy were retrospectively reviewed to evaluate the tendency of recurrence and the risk factors after the antiepileptic drug discontinuation. The population consisted of 59 children who were seizure free for more than 2 years and followed up for more than 1 year after the discontinuation via department of pediatrics, Yonsei University, Wonju College of Medicine. We analyzed risk factors of recurrence(age of seizure onset, seizure frequency before treatment, interval from seizure onset to start of treatment, duration from neurologic disorders, and EEG done just before discontinuation) between non-recurrent group(43 patients) and recurrent group(16 patients). The results were as follows: 1) In 59 patients with epilepsy, 16(27.1%) patients showed recurrence after the discontinuation and 14(87.5%) patients of those were developed during taperring and within less than 1 year. The probability of recurrent seizure by Kaplan-Meier curve at 12 and 24 months after discontinuation are 23.7% and 33.6% respectively. 2) There were significant differences on seizure frequency before treatement, duration from start of treatment to control (9.5months vs 31.1months), and associated neurologic disorders(11.6% vs. 56.2%) between non-recurrent and recurrent group. 3) There were no significant differences on age at seizure onset(70.6 months vs. 58.5months), interval from seizure onset to start of treatment(9.5months vs. 6.6months), length of seizure free(49.7months vs 39.3months), abnormal EEG finding done just before withdrawal(23.2% vs. 25.0% ) between non-recurrent and recurrent group.
Child
;
Electroencephalography
;
Epilepsy*
;
Gangwon-do
;
Humans
;
Nervous System Diseases
;
Pediatrics
;
Recurrence*
;
Retrospective Studies
;
Risk Factors*
;
Seizures
5.Efficacy and Tolerability of Moclobemide Compared with Amitriptyline in Dysthymic Disorder.
Min Soo LEE ; Jong Won NAM ; Ji Hyun CHA ; Young Ku KIM ; Seung Ho RYU
Journal of the Korean Society of Biological Psychiatry 1999;6(1):96-101
BACKGROUND: Since dysthymia begins in late childhood or adolescence and has a chronic course, long-term pharmacotherapy may be required. New generation antidepressant, moclobemide, with more acceptable side effect profiles, is effective in the treatment of dysthymia. The main objective of this study was to determine whether they exhibit comparable efficacy and tolerability in dysthymia to amitriptyline. METHOD AND MATERIALS: The efficacy and tolerability of the moclobemide and amitriptyline, were compared in a eight-week single-centre double-blind study in patients(n=37) with dysthymia using he HAMD-17, the Clinical Global Impression Scale(CGI), the Montgomery-Asberg Depression Rating Scale(MADRS), Efficacy Index-Therapeutic Index(EITE), 4-point Index Side Effect Scale(4-PISES), and Efficacy Index-Side Effect Scale(EISE). RESULTS: A total of 37 patients entered the study, 19 were randomly assigned to the moclobemide group and 18 to be amitriptyline group. Demographic and illness characteristics were similar in both groups. There were no significant difference between two groups at the total 17-HDRS score, the HAMD-17% improvement, the total MADRS score, CGI response, and the EITE. In the comparison of EISE between two groups, the scores of the moclobemide group were relatively lower than the amitriptylinen group in full treatment. And the differences were significant(moclobemide group 1.39+/-0.61 ; amitriptyline group 2.00+/-0.85, p<.001). At the 4-PISE. There was no serious or treatment threatening side effects. And there was no specific difference in side effects between two groups. The moclobemide group reported higher EIR scores than the amitriptyline group at every follow up day, but the differences were not significant. And there was no significant differences in the scores of five HRQOL subcategories which is compared between two groups at every follow up days. CONCLUSIONS: In terms of 17-HDRS and MADRS, moclobemide and amitriptyline are equally effective at least in allevating dysthymic symptoms. But moclobemide tended to be less troubling and better tolerated than amitriptyline. Therefore, moclobemide treatment can be used as a safe, and higher satisfactory treatment strategy for the dysthymia.
Adolescent
;
Amitriptyline*
;
Depression
;
Double-Blind Method
;
Drug Therapy
;
Dysthymic Disorder*
;
Follow-Up Studies
;
Humans
;
Moclobemide*
7.Epidural Emphysema Associated with Subcutaneous Emphysema after Chest Tube Placement: A Case Report.
Ji Young RHO ; Seung Min YOO ; Young Ah CHO ; Sang Min LEE
Tuberculosis and Respiratory Diseases 2010;69(5):389-391
Spinal epidural emphysema is rare and has been described secondary to following medical intervention, such as lumbar puncture and epidural analgesia, pneumothorax or pneumomediastinum, degenerative disk disease, epidural abscess, and trauma. Rarely, it occurs after chest tube placement. We report a case of spinal epidural emphysema incidentally noted on HRCT after chest tube placement.
Analgesia, Epidural
;
Chest Tubes
;
Emphysema
;
Epidural Abscess
;
Epidural Space
;
Mediastinal Emphysema
;
Pneumothorax
;
Spinal Puncture
;
Subcutaneous Emphysema
;
Thorax
;
Tomography, X-Ray Computed
8.CT Diagnosis of Paradoxical Embolism via a Patent Foramen Ovale in a Patient with a Pulmonary Embolism and Prominent Eustachian Valve
Min Ji SON ; Seung Min YOO ; Charles S WHITE
Journal of the Korean Radiological Society 2021;82(2):435-439
While there is a high prevalence of patent foramen ovale in adults, paradoxical embolism via a patent foramen ovale is rare. Previous echocardiographic studies indicated that paradoxical embolism might only occur in patients with high-risk features of patent foramen ovale (i.e., large defect size, presence of a Eustachian valve, and high right atrial pressure). Here, we present a case of patent foramen ovale with high-risk CT features for paradoxical embolism.
9.CT Diagnosis of Paradoxical Embolism via a Patent Foramen Ovale in a Patient with a Pulmonary Embolism and Prominent Eustachian Valve
Min Ji SON ; Seung Min YOO ; Charles S WHITE
Journal of the Korean Radiological Society 2021;82(2):435-439
While there is a high prevalence of patent foramen ovale in adults, paradoxical embolism via a patent foramen ovale is rare. Previous echocardiographic studies indicated that paradoxical embolism might only occur in patients with high-risk features of patent foramen ovale (i.e., large defect size, presence of a Eustachian valve, and high right atrial pressure). Here, we present a case of patent foramen ovale with high-risk CT features for paradoxical embolism.
10.Fibroepithelial polyp of the vulva accompanied by lymphangioma circumscriptum.
Min Hee LEE ; Ji Young HWANG ; Jin Hee LEE ; Dong Hoon KIM ; Seung Hun SONG
Obstetrics & Gynecology Science 2017;60(4):401-404
Fibroepithelial polyp (FEP) and lymphangioma circumscriptum (LC) of the vulva are rare diseases that occur generally in young to middle-aged women. The pathogenesis of FEP is not clearly understood. Several previous cases have suggested that a hormonal influence may be a predisposing condition for developing FEP with or without chronic inflammation. A 68-year-old postmenopausal woman presented with a history of multiple raised lesions on the vulva with a 1-year duration. Additionally, a pedunculated mass had appeared 6 months earlier in the left lower labia minora. The patient underwent simple excision by electrocautery. The final pathological diagnosis was FEP with LC. In this case, the development of FEP was associated only with chronic inflammation induced by LC. Therefore, the case supports the hypothesis that a chronic inflammatory process may be related to the development of FEP even without hormonal influence.
Aged
;
Diagnosis
;
Electrocoagulation
;
Female
;
Humans
;
Inflammation
;
Lymphangioma*
;
Neoplasms, Fibroepithelial
;
Polyps*
;
Polytetrafluoroethylene
;
Postmenopause
;
Rare Diseases
;
Vulva*